Download now: Cannabis Cash

Investing in Western Medicine and Biotechs

Written by Jeff Siegel
Posted October 8, 2020

I want to live a very long and healthy life.

Who doesn’t?  

Right?

This is why I exercise regularly, maintain a healthy diet, and meditate every morning.

Although the latter is something I haven’t been doing very long, I’ve definitely noticed an improvement in my overall mood and stress relief.

Interestingly, as I’ve learned more about meditation and have joined a number of meditation groups, I’ve noticed that I’m oftentimes surrounded by folks who eschew Western medicine entirely and are quick to criticize it for being ineffective and impractical.

But nothing could be further from the truth.

While there are certainly plenty of positive things to be said about nontraditional medicines and therapy, this idea that you’ll live a longer and healthier life by avoiding practical medical science that utilizes pharmaceuticals, biotechnology, and even surgery is absurd. 

Truth is, many of us are alive today because of Western medicine.

The MMR vaccine, for instance, is a testament to the effectiveness of Western medicine. 

Or how about surgical anesthetic?

Would you like to have your appendix removed without it?

Hell, just the ability to have your appendix safely removed is the result of advances made in Western medicine. 

While I’ve certainly benefited from what one might consider nontraditional therapies — such as acupuncture, meditation, herbal medicines, and aromatherapy — I’d be a fool to ignore all the great medical achievements Western medicine has brought us.

I’d be a fool to ignore the investment opportunities from those things as well.

No Big Deal: Just a 105,000% Gain

It’s no secret that pharmaceutical and biotech companies make a ton of scratch.

It’s also no secret that a lot of folks resent these companies making so much money.

While I certainly have no love for greedy CEOs who jack up the prices of lifesaving drugs in an effort to bolster their yearly bonuses, criticizing a pharmaceutical company for making a profit is, for lack of a better word, stupid.

Do you think half of the lifesaving drugs we have today could even exist if it weren’t for these companies making the mountains of cash they need to hire the right talent, develop these products, and actually get them to market?

Not a chance.

And no matter how you slice it, if you can invest early in the small biotech firms that are responsible for creating most of these amazing medical breakthroughs, you can make a fortune while actually supporting new medicines that help people live longer and healthier lives.

Make no mistake: That’s an honorable way to make a buck.

Certainly I’ve built some of my fortune by doing this. 

I’ve always looked at biotechs as long-term investments because the potential gains can be absolutely life-altering. 

Take Biogen (NASDAQ: BIIB), for instance. 

This is one of my favorite biotech plays ever.

I say this because one of my colleagues became stupid rich after buying some shares back in 1994 — for $0.40 each.

By 2015, the stock was trading in excess of $422 a share.

That’s a gain of more than 105,000%

Yes, you read that correctly.

And that means $5,000 worth of Biogen eventually became worth more than $5.3 million.

Most people know Biogen for its work in treating neurological diseases.

But those who were smart enough to buy it early and hold it for the long haul know it for being the single stock that made them multimillionaires.

~~biotech_eac ~~

Of course, not every biotech will deliver like that.

In fact, few ever do.

But every now and again, a new biotech play enters the scene that makes seasoned biotech millionaires salivate.  

And one of those stocks is a tiny play on a new treatment that can potentially stop, slow, or even reverse age-related diseases while restoring human health.

Make no mistake: This is a Hail Mary, but so was Biogen when it first started trading.

Now in a few weeks, this particular company is expected to begin FDA clinical trials on a new treatment it’s testing.

If this treatment proves successful, the stock could eventually mimic what we saw with Biogen.  

So that’s why I wrote up this brief report on the company, the treatment it's developing, and what the technology could be worth upon successful completion of FDA trials.

I’ll give you a hint — it’s in the billions!

Of course, biotechs aren’t for everybody.

Certainly they don’t always pay off overnight.

It took many years for early Biogen investors to become millionaires.

But given that you could potentially make more than $1 million on a single stock, I suspect most folks would be willing to wait a few years for that kind of score.

Click here to learn more.

To a new way of life and a new generation of wealth...

Jeff Siegel Signature

Jeff Siegel

follow basic@JeffSiegel on Twitter

Jeff is the founder and managing editor of Green Chip Stocks, a private investment community that capitalizes on opportunities in alternative energy, organic food markets, legal cannabis, and socially responsible investing. He has been a featured guest on Fox, CNBC, and Bloomberg Asia, and is the author of the best-selling book, Investing in Renewable Energy: Making Money on Green Chip Stocks. For more on Jeff, go to his editor's page.

Hydrogen Fuel Cells: The Downfall of Tesla?